1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Innovex

Anonymous board for Innovex.

Sort By:
Title
Replies Views ↓
Last Message
  1. Anonymous
    Replies:
    316
    Views:
    118,678
  2. Anonymous
    Replies:
    53
    Views:
    81,846
  3. Anonymous
    Replies:
    502
    Views:
    34,864
  4. Anonymous
    Replies:
    69
    Views:
    29,768
  5. Anonymous
    Replies:
    161
    Views:
    25,093
  6. Anonymous
    Replies:
    194
    Views:
    24,831
  7. Anonymous
    Replies:
    197
    Views:
    18,660
  8. Anonymous
    Replies:
    75
    Views:
    18,095
  9. Anonymous
    Replies:
    29
    Views:
    15,987
  10. Anonymous
    Replies:
    19
    Views:
    15,792
  11. Anonymous
    Replies:
    85
    Views:
    14,888
  12. Anonymous
    Replies:
    101
    Views:
    12,738
  13. Anonymous
    Replies:
    97
    Views:
    10,680
  14. Anonymous
    Replies:
    125
    Views:
    9,213
  15. Anonymous
    Replies:
    131
    Views:
    8,795
  16. Anonymous
    Replies:
    73
    Views:
    8,609
  17. Anonymous
    Replies:
    8
    Views:
    8,502
  18. Anonymous
    Replies:
    84
    Views:
    8,210
  19. Anonymous
    Replies:
    6
    Views:
    8,199
  20. Anonymous
    Replies:
    13
    Views:
    8,066

Thread Display Options

Loading...